PTK2B and glioblastoma: An initial cohort of 19 GBM PDX were kinomically profiled using the PamStation12 peptide substrate microarray platform (protein tyrosine kinase, or PTK PamChip) and phosphopeptide probe intensities were plotted versus PDX survival when implanted intracranially.